RecruitingNot ApplicableNCT06753214

Telemedicine Education for Caregivers and Asthma Control in Children

Effectiveness of Telemedicine-Based Education for Caregivers on Asthma Control in Children With Uncontrolled Asthma: A Randomized Controlled Trial


Sponsor

Can Tho University of Medicine and Pharmacy

Enrollment

64 participants

Start Date

Jun 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Asthma control in pediatric patients remains a critical issue for healthcare providers. Telemedicine has emerged as an effective solution for overcoming distance barriers in healthcare delivery. This study aims to utilize telemedicine-based education for caregivers to improve asthma control in children with uncontrolled asthma. By providing remote guidance and support, the study seeks to enhance caregivers' knowledge and management practices, ultimately leading to better asthma outcomes for pediatric patients.


Eligibility

Min Age: 4 YearsMax Age: 16 Years

Inclusion Criteria1

  • Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department.

Exclusion Criteria5

  • Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire.
  • Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors.
  • Pediatric patients who have siblings participating in the study.
  • Patients currently participating in another clinical study (excluding non-interventional studies or registries).
  • Failure to return for a second visit within 6 months following enrollment.

Interventions

OTHERTelemedicine-Based Education

Intervention through telemedicine

OTHERStandard Care (in control arm)

Sham comparator through telemedicine


Locations(1)

Can Tho Children's Hospital

Can Tho, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06753214


Related Trials